Medicamen Organics Limited specializes in developing, manufacturing, and distributing a diverse range of pharmaceutical products including tablets, capsules, syrups, and dry powders.

The company is strategically focused on global expansion, notably entering the Nepalese market through a partnership with Medi Hub Organic Limited, complemented by a new subsidiary, Grande Etoile Pharmaceuticals.

Medicamen witnessed a substantial 51% increase in revenue year-on-year and a 54% rise in PAT, driven by its strategic initiatives and operational efficiencies.

The company is capitalizing on consumer trends in the global beauty market with its new endeavor into cruelty-free cosmetics and skincare, aiming for a significant share in the $700 billion market.

Medicamen recently issued 4,65,910 convertible warrants on a preferential basis to the Promoter Group to raise INR3 crores, strengthening its working capital for further growth.